EXHIBIT E

Schedule A
Core Strategies

States and Qualifying Block Grantees shall choose from among the abatement strategies listed in
Schedule B. However, priority shall be given tothe following core abatement strategies (“Core
Sirategies").

A. NALOXONE OR OTHER FDA-APPROVED DRUG TO
REVERSE OPIOID OVERDOSE!

1. Expand training for first responders, schools, community
support groups and families; and

2. Inctease distribution to individuals who are uninsured oF
Whose insurance does not cover the needed service

B,  MEDICATION-ASSISTED TREATMENT (“MAT™)
DISTRIBUTION AND OTHER OPIOID-RELATED,
‘TREATMENT

1, Increase distribution of MAT to individuals who are
uninsured of Whose insurance does not cover the needed

2. Provide education to school-based and youth- focused.
‘programs that discourage of prevent misuse:

3. Provide MAT education and awareness training to
healthcare providers, EMTs, law enforcement, and other
first responders; and

4. Provide treatment and recovery support services such as,
residential and inpatient treatment, intensive outpatient
‘treatment, outpatient therapy or counseling, and recovery
‘housing that allow of integrate medication and with other
support services

TH As used in this Schedule A, words like “expand,” “fund,”
indicate a preference for NeW oF existing programs.

provide" or the like shall not

El

_Page: 1

PREGNANT & POSTPARTUM WOMEN

1, Expand Screening, Brief Intervention, and Referral to
Treatment (°S es 1o non-Medicaid eligible or

2. Expand comprehensive evidence-based treatment and
recovery services, including MAT, for women with co-
‘occurring Opioid Use Disorder ("OUD") and other
Substance Use Disorder (“SUD" Mental Health disorders
for uninsured individuals for up to 12 months postpartum;
and

3. Provide comprehensive wrap-around services to individuals
With OUD, including housing, transportation, job
placemenvraining, and childcare,

EXPANDING TREATMENT FOR NEONATAL,
INENCE SYNDROME (“VAS

1. Expand comprehensive evidence-based and recovery
support for NAS babies

2. Expand services for better continuum of eare with infant-
need dyad: and
3. Expand long-term treatment and services for medical

monitoring of NAS babies and their families

EXPANSION OF WARM HAND-OFF PROGRAMS AND
RECOVERY SERVICE:

1, Expand services such as navigators and on-call teams to
begin MAT in hospital emergeney departments;

2. Expand warm hand-off services to transition to recovery
3. Broaden scope of recovery services to include eo-oceuet

SUD or mental health conditions;

4. Provide comprehensive wrap-around services to individuals
in recovery, including housing, transportation, job
placemenvtraining, and childcare; and

5, Hite additional social workers or other behavioral health
workers to facilitate expansions above,

E2

_Page: 2

‘TREATMENT FOR INCARCERATED POPULATION

1, Provide evidence-based treatment and recovery support
including MAT for persons with OUD and co-occurring
SUD/MI disorders within and transitioning out of the
‘criminal justice system; and

Increase funding for jails to provide treatment to inmates
with OUD.

PREVENTION PROGRAMS

1, Funding for media campaigns to prevent opioid use (similar
to the FDA's “Real Cost” campaign to prevent youth from
misusing tobacco)

Funding for evidence-based prevention programs in
schools;

3. Funding for medical provider education and outreach
regarding best prescribing practices for opioids consistent
With the 2016 CDC guidelines, including providers at
hospitals (academic detailing):

4. Funding for community drug disposal programs; and

Funding and training for first responders to participate in
pre-arrest diversion programs, post-overdose response
teams, or similar strategies that connect at-risk individuals
to behavioral health services and supports

EXPANDIN

.VRINGE SERVICE PROGRAMS

1, Provide comprehensive syringe services programs with
more wrap-around services, including linkage to OUD.
‘treatment, access to sterile syringes and linkage to care and.
‘weatment of infectious diseases,

THE EFFECT!
‘ABATEMENT STRATEGIES WITHIN THE STATE

ES

_Page: 3

Support treatment of Opioid Use Disorder (OUD) at

Schedule B
Approved Uses

any co-occurring Substance Use Disorder

‘or Mental Health (SUD/ME) conditions through evidence-based or evidence-informed programs
‘or strategies that may include, but are not limited to, the Following

PART ONE: TREATMENT

A. TREAT OPIOID USE DISORDER (OUD)

‘Support treatment of Opioid Use Disorder (“OUD”) and a

co-occurring Substance Use

Disorder or Mental Health (“SUD/MI") conditions through evidence-based or evidence-
informed programs or strategies that may include, but are not limited to, those that:!®

TS As used i

Expand availability of teatment for OUD and any co-occurring SUDIMH.
conditions, including all forms of Medication-Assisted Treatment (“MAT”)
approved by the U.S. Food and Drug Administration,

‘Support and reimburse evidence-based services that adhere tothe American
Society of Addiction Medicine (“AS4I/") continuum of eare for OUD and any co-
‘occurring SUD/MHT conditions

Expand telehealt to increase access to weatment for OUD and any co-occurring
SUD/MH conditions, including MAT, as well as counseling, psychiatric support,
and other treatment and recovery support services.

Improve oversight of Opioid Treatment Programs (“O7P3") to assure evidence-
based or evidence-informed practices such as adequate methadone dosing and low
threshold approaches to treatment.

Support mobile intervention, treatment, and recovery services, offered by
‘qualified professionals and service providers, such as peer recovery coaches, for
persons with OUD and any co-occurring SUD/MH conditions and for persons
‘who have experienced an opioid overdose

Provide treatment of trauma for individuals with OUD (e., violence, sexual
assault, human trafficking, or adverse childhood experiences) and family
members (eg. surviving family members after an overdose or overdose fatality),
and training of health care personnel to identify and address such trauma,

Support evidence-based withdrawal management services for people with OUD
and any co-occurring mental health conditions.

this Schedule B, words like “expand,” “fund,” “provide” or the like shall not

indicate a preference for NeW oF existing programs.

E4

_Page: 4

Provide training on MAT for health care providers, fist responders, students, or
‘other supporting professionals, such as peer recovery coaches or recovery
‘outreach specialists, including telementoring to assist community-based providers
in sural or underserved areas

Support workforce development for addiction professionals who work with
persons with OUD and any co-occurring SUD/MH conditions.

Offer fellowships for addiction medicine specialists for direct patient care,
instructors, and clinical research for treatments.

Offer scholarships and supports for behavioral health practitioners or workers
involved in addressing OUD and any co-occurring SUD/MH of mental health
conditions, including, but not limited to, training, scholarships, fellowships, loan
repayment programs, or other incentives for providers to work in rural or
underserved areas.

Provide funding and taining for clinicians to obtain a waiver under the Federal
Drug Addiction Treatment Act of 2000 (“DATA 2000") 10 preseribe MAT for
‘OUD, and provide technical assistance and professional support to clinicians who
have obtained a DATA 2000 waiver.

Disseminate of web-based training curricula, such as the American Academy of
‘Addiction Psyehiatry’s Provider Clinical Support Service-Opioids web-based
‘waining curriculum and motivational interviewing.

Develop and disseminate new curricula, such as the American Academy of
‘Addiction Psyehiatry’s Provider Clinical Support Service for Medication
‘Assisted Treatment.

‘SUPPORT PEOPLE IN TREATMENT AND RECOVERY

Support people in recovery from OUD and any co-occuti
through evidence-based of evidence-informed programs or strategies that may

SUD/MH conditions

ude,

Dut are not limited to, the programs or strategies that:

Provide comprehensive wrap-around services to individuals with OUD and any
0-occurring SUD/MH conditions, including housing, transportation, education,
job placement, ob traning, or childcare.

Provide the full continuum of care of treatment and recovery serviees for OUD
and any co-occurring SUD/MH conditions, including supportive housing, peer
support services and counseling, community navigators, case management, and
‘connections to community-based services.

Provide counseling, peer-support, recovery case management and residential
‘weatment with access to medications for those who need it to persons with OUD
‘and any co-occurring SUD/MHT conditions.

ES

_Page: 5

Provide access to housing for people with OUD and any co-occurring SUD/MH.
conditions, including supportive housing, recovery housing, housing assistance
programs, taining for housing providers, or recovery housing programs that allow
Or integrate FDA-approved mediation with other support services.

Provide community support services, including social and leyal services, to assist,
in deinstitutionalizing persons with OUD and any co-occurring SUD/MIL
conditions.

‘Support or expand peet-recovery centers, which may include support groups,
social events, computer access, or other Services for persons with OUD and any
‘co-occurring SUD/MH conditions.

Provide or support transportation to teatment or recovery programs or services
for persons with OUD and any co-occurring SUD/MH conditions

Provide employment training or educational services for persons in treatment for
‘of recovery from OUD and any co-occurring SUD/MH conditions.

dentify successful recovery programs such as physician, pilot, and college
recovery programs, and provide support and technical assistance to inerease the
‘number and capacity of high-quality programs to help those in recovery

Engage non-profits, faith-based communities, and community coalitions to
support people in treatment and recovery and to support family members in thie
efforts to support the person with OUD in the family

Provide training and development of procedures for government staff t0
appropriately interact and provide social and other services to individuals with or
in recovery ftom OUD, including reducing stigma.

Support stigma reduction efforts regarding treatment and support for persons with
‘OUD, including reducing the stigma on effective weatment.

Create or support culturally appropriate services and programs for persons with
‘OUD and any co-occurring SUD/MH conditions, including new Americans.

Create andior support recovery high schools.

Hie or train behavioral health workers to provide or expand any of the services or
supports listed above.

CONNECT PEOPLE WHO NEED HELP TO THE HELP THEY NEED
(CONNECTIONS TO CARE}

Provide connections to care for people who have—or are at risk of developing OUD
‘and any co-occurring SUD/MHT conditions through evidence-based or evidenoe-informed

programs or strategies that may i

ude, but ae not limited to, those that

E6

_Page: 6

Ensure that health care providers are screening for OUD and other risk factors and
‘know how to appropriately counsel and treat (or refer ifnecessary) a patient for
‘OUD treatment,

Fund SBIRT programs to reduce the transition from use to disorders, including
SBIRT services to pregnant women who are uninsured or not eligible for
Medicaid.

Provide training and long-term implementation of SBIRT in key systems (health,
Schools, colleges, criminal justice, and probation), with a focus on youth and
‘young adults when transition from misuse to opioid disorder is common,

Purchase automated vers
technology.

of SBIRT and support ongoing costs of the

Expand services such as navigators and on-call teams to begin MAT in hospital
‘emergency departments.

Provide training for emergency room personnel treating opioid overdose patients
‘on post-discharge planning, including community referrals for MAT, recovery
‘ease management or support services

Support hospital programs that transition persons with OUD and any co-oceut
SUD/MH conditions, or persons who have experienced an opioid overdose, into
Clinically appropriate follow-up care through a bridge cline or similar approach,

Support crisis stabilization centers that serve as an alternative to hospital
‘emergency departments for persons with OUD and any co-occurring SUD/MHL
‘conditions or persons that have experienced an opioid overdose

Support the work of Emergeney Medical Systems, including peer support
specialists to connect individuals to treatment or other appropriate services
following an opioid overdose or other opioid-rlated adverse event.

Provide funding for peer support specialists or recovery coaches in emergency
departments, detox facilities, recovery centers, recovery housing, or similar
seltings; offer Services, supports, or connections to care to persons with OUD and
any co-occurring SUD/MH conditions of to persons who have experienced an
‘opioid overdose.

Expand warm hand-off services to transition to recovery services

Create or support school-based contacts that parents can engage with to seek
immediate treatment services for their child; and support prevention, interventio
‘treatment, and recovery programs focused on young people

Develop and support best practices on addressing OUD in the workplace.

ET

_Page: 7

14, Support assistance programs for health care providers with OUD.

15, Engage non-profits and the faith community asa system to support outreach for
‘reatment

16, Support centralized call centers that provide information and connections to
appropriate services and supports for persons with OUD and any co-occurring
SUD/MH conditions.

ADDRESS THE NEEDS OF CRIMINAL JUSTICE-INVOLVED PERSONS

Address the needs of persons with OUD and any co-occurring SUD/MH conditions who
are involved in, are at risk of becoming involved in, o are transitioning out of the
‘criminal justice system through evidence-based or evidence-informed programs oF
strategies that may include, but are not limited to, those that

1. Support pre-arrest or pre-arraignment diversion and deflection strategies for
persons with OUD and any co-oceurring SUD/MH conditions, including
established strategies such as

1, Self-referal strategies such asthe Angel Programs or the Police Assisted
‘Addiction Recovery Initiative (“PAART");

2. Active outreach strategies such as the Drug Abuse Response Team
( DART") model
3, “Naloxone Plus” strategies, which work to ensure that individuals who

have received naloxone to reverse the effects of an overdose are then
linked to treatment programs or other appropriate services;

4. Officer prevention strategies, such as the Law Enforcement Assisted
Diversion (“LEAD”) model;

5. Officer intervention strategies such as the Leon County, Florida Adult
Civil Citation Network or the Chicago Westside Narcotics Diversion to
‘Treatment Initiative; ot

6. Co-tesponder and/or alternative responder models to address OUD-related
‘911 calls with greater SUD expertise
2. Support pre-trial services that connect individuals with OUD and any co-
‘occurring SUD/MH conditions to evidence-informed treatment, including MAT,
and related services

3. Support treatment and recovery courts that provide evidence-based options for
ppetsons with OUD and any co-occurring SUD/MH conditions.

ES

_Page: 8

4. Provide evidence-informed treatment, inluding MAT, recovery support, harm
reduetion, or other appropriate services to individuals with OUD and any co-
‘occurring SUD/MH conditions who are incarcerated in jail or prison,

5. Provide evidence-informed treatment, including MAT, recovery support, harm
reduetion, or other appropriate services to individuals with OUD and any co-
‘occurring SUD/MH conditions who are leaving jail or prison or have recently left
jail or prison, are on probation ot parole, are under community corrections
supervision, or are in re-entry programs oF facilities.

6 Support critical time interventions ("C77"), particulary for individuals living with
‘dual-diagnosis OUD/serious mental illness, and services for individuals who face
immediate risks and service needs and risks upon release from correctional
settings.

7. Provide raining on best practices fr addressing the needs of criminal juste
involved persons with OUD and any co-occurring SUD/MH conditions to law
‘enforcement, correctional, or judicial personnel or to providers of treatment,
recovery, harm reduction, ease management, or other services offered in
‘connection with any of the strategies described in this section.

ADDRESS THE NEEDS OF PREGNANT OR PARENTING WOMEN AND
‘THEIR FAMILIES, INCLUDING BABIES WITH NEONATAL ABSTINENCE
‘NDROME

‘Address the needs of pregnant or parenting women with OUD and any co-occurring
SUD/MH conditions, and the needs oftheir families, including babies with neonatal
abstinence syndrome (“NAS"), through evidence-based or evidence-informed programs
or strategies that may include, but are not limited to, those that

1, Support evidence-based or evidence-informed treatment, including MAT,
recovery services and supports, and prevention services for pregnant women—or
women who could become pregnant-—who have OUD and any co-occurring
SUD/MH conditions, and other measures to educate and provide support to
families affected by Neonatal Abstinence Syndrome.

2. Expand comprehensive evidence-based treatment and recovery services, including
MAT, for uninsured women with OUD and any co-occurring SUD/MH
‘conditions for up to 12 months postpartum,

3. Provide traning for obstetricians or other healtheare personnel who work with
pregnant women and their families regarding treatment of OUD and any eo
‘occurring SUD/MHT conditions

4. Expand comprehensive evidence-based treatment and recovery support for NAS
babies; expand services for better continuum of care with infant-need dyad; and
‘expand long-term treatment and services for medical monitoring of NAS babies
and ther families

E9

_Page: 9

Provide training to health care providers who work with pregnant or parenting
women on best practices for compliance with federal requirements that children
‘born with NAS get referred to appropriate services and receive a plan of safe care

Provide child and family supports for parenting women with OUD and any eo
‘occuring SUD/MHT conditions

Provide enhanced family support and child cate services for parents with OUD
‘and any co-occurring SUD/MHT conditions.

Provide enhanced support for children and family members suffering trauma as @
result of addiction inthe family: and offer trauma-informed behavioral health
‘eatment for adverse childhood events,

Offer home-based wrap-around services to persons with OUD and any co-
‘occurring SUD/MH conditions, including, but not limited to, parent skills
waining.

Provide support for Children’s Serviees—Fund additional positions and services,
including supportive housing and other residential services, relating to children
being removed from the home and/or placed in foster care due to custodial opioid

PART TWO: PREVENTION,

PREVENT OVER-PRESCRIBING AND ENSURE APPROPRIATE,

PRESCRIBING AND DISPENSING OF O1

IDS

Support efforts to prevent over-prescribing and ensure appropriate prescribing and
dispensing of opioids through evidence-based or evidence-informed programs or
strategies that may include, but are not limited to, the following:

Funding medical provider education and outreach regarding best prescribing
practices for opioids consistent with the Guidelines for Prescribing Opioids for

‘Chronic Pain from the U.S. Centers for Disease Control and Prevention, including
providers at hospitals (academic detailing).

‘Training for health care providers regarding safe and responsible opioid
prescribing, dosing, and tapering patients off opioids.

Continuing Medical Education (CME) on appropriate preseribing of opioids
Providing Support for non-opioid pain treatment alternatives, including training

providers to offer or refer to multi-modal, evidence-informed treatment of pain,

Supporting enhancements or improvements to Prescription Drug Monitoring
Programs (“PDMPS"), including, but not limited to, improvements that


_Page: 10

fom

1. Increase the number of preseribers using PDMPs;

2. Improve point-of-care decision-making by increas
‘or format of data available to prescribers using PDMPs, by impro\
interface that prescribers use to access PDMP data, o both; of

ng the quantity, quality,
the

3. Enable states to use PDMP data in support of surveillance or intervention
strategies, including MAT referrals and follow-up for individuals
identified within POMP data as likely to experience OUD in a manner that
‘complies with all relevant privacy and security laws and rules.

6, Ensuring PDMPs incorporate available overdose/naloxone deployment dat,
including the United States Department of Transportation's Emergeney Medical
‘Technician overdose database in a manner that complies with al relevant privacy
and security laws and rules,

7. Increasing electronic prescribing to prevent diversion oF forgery.

8, Educating dispensers on appropriate opioid dispensing.

Support efforts to discourage or prevent misuse of opioids through evidence-based or
cevidence-informed programs or strategies that may include, but are not limited to, the
following:

1. Funding media campaigns to prevent opioid misuse.

2. Comective advertising oF affirmative public education campaigas based o
evidence

3. Public education relating to drug disposal

4. Drug take-back disposal or destruction programs.

5. Funding community anti-drug coalitions that engage in drug prevention efforts.

6. Supporting community coalitions in implementing evidence-informed prevention,

such as reduced social access and physical access, stigma reduction—including
staffing, educational campaigns, support for people in treatment or recovery, ot
‘taining of coalitions in evidence-informed implementation, including the
Strategic Prevention Framework developed by the U.S. Substance Abuse and
Mental Health Services Administration (“SAMHSA).

7. Engaging non-profits and faith-based communities as systems to support
prevention.

_Page: 11

Funding evidence-based prevention programs in schools or evidence-informed
school and community education programs and campaigns for students, families,
school employees, school athletic programs, parent-teacher and student
associations, and others.

School-based or youth-focused programs or strategies that have demonstrated
effectiveness in preventing drug misuse and seem likely to be effective in
preventing the uptake and use of opioids

Create or support community-based education of intervention services for
families, youth, and adolescents at risk for OUD and any co-occurring SUD/MHL
conditions.

Support evidence-informed programs or curricula to address mental health needs
‘of Young people who may be at risk of misusing opioids or other drugs, inclu
‘emotional modulation and resilience skills.

Support greater access to mental health services and supports for young people,
including services and supports provided by school nurses, behavioral health
‘workers or other school staf, to address mental health needs in young people that
(when not properly addressed) inerease the risk of opioid or another drug misuse.

PREVENT OVERDOSE DEATHS AND OTHER HARMS (HARM REDUCTION)

Support efforts to prevent or reduce overdose deaths or other opioid-telated harms

through evidence-based of evidence-informed programs or strategies that may

ude,

Dut are not limited to, the folowing:

Increased availability and distribution of naloxone and other drugs that eat
‘overdoses for first responders, overdose patients, individuals with OUD and their
fiends and family members, schools, community navigators and outreach
‘workers, persons being released from jail or prison, or other members of the
‘general public

Public health entities providing free naloxone to anyone in the community
‘Training and education regarding naloxone and other drugs that teat overdoses
for frst responders, overdose patients, patients taking opioids, families, schools,
‘community support groups, and other members of the general public.

Enabling school nurses and other school staf 1 respond to opioid overdoses, and
provide them with naloxone, taining, and support.

Expanding, improving, or developing data tracking software and applications for

‘overdoses/naloxone revivals,

Public education relating to emergency responses to overdoses,

_Page: 12

7. Public education relating to immunity and Good Samaritan laws.

8, Educating first responders regarding the existence and operation of immunity and
Good Samaritan laws.

9, Syringe service programs and other evidence-informed programs to reduce harms
associated with intravenous drug use, including supplies, staffing, space, peer
support services, referrals to treatment, fentanyl checking, connections to care,
‘and the full range of harm reduction and treatment services provided by these
programs.

10, Expanding access to testing and treatment for infectious diseases such as HIV and
Hepatitis C resulting from intravenous opioid use

11, Supporting mobile units that offeror provide referrals to harm reduction services,
‘treatment, recovery supports, health care, or ther appropriate services to persons
that use opioids or persons with OUD and any co-occurring SUD/MH conditions,

12, Providing training in harm reduction strategies to health care providers, students,
peer recovery coaches, recovery outreach specialists or other professionals that
provide care to persons who use opioids or persons with OUD and any eo
‘occurring SUD/MIHT conditions

13. Supporting screening for fentanyl in routine clinical toxicology test

PART THREE: OTHER STRATEGIES
RESPONDERS

In addition to items in section C, D and H relating to first responders, support the
following:

Education of law enforcement or other first responders regarding appropriate
practices and precautions when dealing with fentanyl or other drugs.

Provision of wellness and support services for frst responders and others who
‘experience secondary trauma associated with opioid-related emergency events

LEADERSHIP, PLANNING AND COORDINATION

Support efforts to provide leadership, planning, coordination, faciitations, training and
technical assistance to abate the opioid epidemic through activities, programs, ot
strategies that may include, but are not limited to, the following

Statewide, regional, local or community regional planning to identify root causes
‘of addiction and overdose, goals for reducing harms related tothe opioid
epidemic, and areas and populations with the greatest needs for teatment


_Page: 13

intervention services, and to support taining and technical assistance and other
strategies to abate the opioid epidemic described inthis opioid abatement strategy
list.

2. A dashboard to (a) share reports, recommendations, or plans to spend opioid
settlement funds; (b) to show how opioid settlement funds have been spent; (c) to
report program or strategy outcomes; or (d) to track, share or visualize key opioid-
‘of health-felated indicators and supports as identified through collaborative
statewide, regional, local or community processes.

3. Invest in infrastructure of staffing at government or not-for-profit agencies to
support collaborative, cross-system coordination with the purpose of preventing
‘overprescribing, opioid misuse, of opioid overdoses, treating those with OUD an
any co-occurring SUD/MH conditions, supporting them in treatment or recovery,
‘connecting them to care, or implementing other strategies to abate the opioid
‘epidemic described in this opioid abatement strategy list.

4, Provide resources to staf government oversight and management of opioid
abatement programs,

‘TRAINING
In addition to the training referred to throughout this document, support training to abate
the opioid epidemic through activities, programs, or strategies that may include, but are

‘not limited to, those that:

1, Provide funding for staff training oF networking programs and services to improve
the capability of government, community, and not-for-profit entities to abate the
opioid crisis,

2. Support infrastructure and staffing for collaborative cross-system coordination to
prevent opioid misuse, prevent overdoses, and treat those with OUD and any co-
‘occurring SUD/MH conditions, or implement other strategies to abate the opioid
epidemic described in this opioid abatement strategy list (e.g, health eare,
primary care, pharmacies, PDMPs, ec.)

RESEARCH
Support opioid abatement research that may include, but isnot limited to, the following:

1. Monitoring, surveillance, data collection and evaluation of programs and
strategies deseribed in this opioid abatement strategy list.

2. Research non-opioid treatment of chronic pain.
3. Research on improved service delivery for modalities such as SBIRT that
demonstrate promising but mixed results in populations vulnerable to

opioid use disorders.

_Page: 14

Research on novel harm reduction and prevention efforts such as the
provision of fentanyl test strips.

Research on innovative supply-side enforcement efforts such as improved
detection of mail-based delivery of synthetic opioids.

Expanded research on swifleertain/air models to reduce and deter opioid
misuse within criminal justice populations that build upon promising
approaches used to address other substances (e.g, Hawaii HOPE and
Dakota 24/7),

Epidemiological surveillance of OUD-related behaviors in critical
populations, including individuals entering the criminal justice system,
including, but not limited to approaches modeled on the Artestee Drug
‘Abuse Monitoring ("ADAM") system,

‘Qualitative and quantitative research regarding public health risks and
‘harm reduction opportunities within illicit drug markets, including surveys.
‘of market participants who sell or distribute ilicit opioids

Geospatial analysis of access barriers to MAT and their association with
‘wealment engagement and treatment outcomes.

_Page: 15

